Task: Answer the multiple-choice question.
Query: Which drug has a -4.712% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) Cc1nc(SC(C)C(=O)NCC2CCCO2)c2cc(-c3ccccc3)sc2n1
b.) CCC1Oc2ccccc2N(CC(=O)NCCCN2CCOCC2)C1=O
Answer: b. CCC1Oc2ccccc2N(CC(=O)NCCCN2CCOCC2)C1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC1Oc2ccccc2N(CC(=O)NCCCN2CCOCC2)C1=O
CCC1Oc2ccccc2N(CC(=O)NCCCN2CCOCC2)C1=O
2-(2-ethyl-3-oxo-1,4-benzoxazin-4-yl)-N-(3-morpholin-4-ylpropyl)acetamide